← Back to Clinical Trials
Recruiting NCT05901493

NCT05901493 Category Learning Retention in Adults With and Without Developmental Language Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05901493
Status Recruiting
Phase
Sponsor University of Delaware
Condition Developmental Language Disorder
Study Type INTERVENTIONAL
Enrollment 540 participants
Start Date 2022-10-23
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
Perceptual category training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 540 participants in total. It began in 2022-10-23 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Approximately 7% of the population experiences developmental language disorder (DLD), a language disorder with unclear causes. DLD affects communication beyond adolescence and poses challenges for education and career advancement due to difficulties in learning and memory. Recent research suggests that adults with DLD struggle with overnight memory consolidation, indicating a need for effective learning and memory support. This project aims to determine the optimal training schedule for perceptual memory retention in adults with and without DLD. The study involves recruiting 240 adults (120 with DLD, 120 without) for speech-perceptual training with different training schedules. The researchers predict that the manipulation of training schedules will interact with circadian preference and overnight consolidation, leading to the discovery of the best practice schedule for speech sound retention. Additionally, 300 more adults (150 with DLD, 150 without) will be recruited to investigate how optimal training schedules interact with reflexive and reflective learning strategies. The time course of learning and retention will be tracked during reflexive and reflective categorization training in six different training schedules.

Eligibility Criteria

Inclusion Criteria: * native speakers of American English * Grew up in a household in which only American English was spoken * 18-55 years of age * Typical vision \& hearing * (Aim 2) access to headphones/devices capable of accessing experiment script via internet * Must meet criteria for Group membership as either TD or DLD Exclusion Criteria: * History of neurological disorders * History of psychiatric disorders * History of socio-emotional disorders * On prescription medication(s) that alter sleep

Contact & Investigator

Central Contact

Frances Earle, PhD

✉ fsearle@udel.edu

📞 6468128376

Frequently Asked Questions

Who can join the NCT05901493 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Developmental Language Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05901493 currently recruiting?

Yes, NCT05901493 is actively recruiting participants. Contact the research team at fsearle@udel.edu for enrollment information.

Where is the NCT05901493 trial being conducted?

This trial is being conducted at Newark, United States, Boston, United States.

Who is sponsoring the NCT05901493 clinical trial?

NCT05901493 is sponsored by University of Delaware. The trial plans to enroll 540 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology